<DOC>
	<DOCNO>NCT02399228</DOCNO>
	<brief_summary>The initial propose clinical study conduct adult head neck cancer subject . This open-labeled , proof concept trial evaluate efficacy , safety tolerability EISO form oral rinse adjunctive therapy standard care . Santalis believe propose study prudent appropriate approach investigate potential product prevent improve oral mucositis symptom commonly see subject undergoing radiotherapy without chemotherapy .</brief_summary>
	<brief_title>A Mouth Rinse Containing East Indian Sandalwood Oil ( EISO ) Prevention Treatment Oral Mucositis</brief_title>
	<detailed_description>The objective proof concept trial : evaluate efficacy , safety tolerability SAN005 administer adult prevention treatment radiation induce oral mucositis . Subjects instructed administration study medication thrice daily till oral mucositis resolve . Subjects return clinic week receive radiation every two week radiation complete mucositis resolve Final Study Visit . Preliminary Efficacy Evaluation severity pain rat NRPS mucositis grade RTOG criterion Visit 7 ( Day 36 ) . Additional secondary efficacy evaluation include severity pain rat NRPS mucositis grade RTOG criterion study visit , frequency PEG tube feed duration treatment weight loss baseline Visit 5 7 . The time mucositis onset duration also use assess efficacy . Additional secondary exploratory endpoint outline statistical analysis plan . The overall efficacy determine compare data historical control . Safety assess evaluate adverse event ( AEs ) respect severity , duration , relationship study drug . In addition tolerability evaluation perform study visit .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>1 . Subjects head neck cancer involve oropharynx oral cavity , expect undergo high dose radiation therapy ( i.e. , â‰¥ 60 Gy ) typically result oral mucositis , without concurrent chemotherapy biologic target therapy . 2 . At least 18 year age 3 . Estimated survival least 6 month . 4 . No prior radiation therapy head neck area , chemotherapy within last year except induction chemotherapy deliver ( deliver ) prior current course radiation therapy 5 . Female subject childbearing potential must agree use adequate form contraceptive ( e.g. , hormonal , barrier method abstinence ) prior study entry duration trial . 6 . Are willing refrain use treatment oral mucositis consult study investigator ( ) . 7 . Are able give write informed consent manner approve Institutional Review Board comply requirement study . 1 . Have preexist mucositis cause . 2 . Are immunosuppressed chronic use immunosuppressive drug . 3 . Have know sensitivity constituent test product include sensitivity sandalwood oil , fragrances member Compositae family vascular plant ( e.g. , sunflower , daisy , dahlia , etc. ) . 4 . ECOG performance status &gt; 3 5 . Unwilling unable follow protocol requirement . 6 . Have condition opinion investigator would confound efficacy , safety tolerability assessment , oral thrush . 7 . Have participate clinical trial previous 30 day . 8 . Are pregnant , breastfeeding , unwilling practice acceptable form birth control study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>radiation therapy</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>head neck cancer</keyword>
</DOC>